Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

The clinical relevance of recurrent venous thromboembolism (VTE) after discontinuing anticoagulation in patients with COVID-19-associated VTE remains uncertain. We estimated the incidence rates and mortality of VTE recurrences developing after discontinuing anticoagulation in patients with COVID-19-...

ver descrição completa

Detalhes bibliográficos
Autores: Jara Palomares, Luis, Bikdeli, Behnood, Jiménez, David, Muriel, Alfonso, Demelo-Rodríguez, Pablo, Moustafa, Farès, Villalobos, Aurora, López-Miguel, Patricia, López-Jiménez, Luciano, Otálora, Sonia, Peris, María Luisa, Amado, Cristina, Chopard, Romain, Rivera-Cívico, Francisco, Monreal, Manuel
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/386568
Acesso em linha:http://hdl.handle.net/10261/386568
https://api.elsevier.com/content/abstract/scopus_id/85193906758
Access Level:acceso abierto
Palavra-chave:Anticoagulation
COVID-19
Pulmonary embolism
SARS-CoV-2
Venous thromboembolism
Descrição
Resumo:The clinical relevance of recurrent venous thromboembolism (VTE) after discontinuing anticoagulation in patients with COVID-19-associated VTE remains uncertain. We estimated the incidence rates and mortality of VTE recurrences developing after discontinuing anticoagulation in patients with COVID-19-associated VTE.

Registos relacionados